Home NKMax

NKMax

In operation
IPO
Developer of Cellular Immunotherapy
Basic
Enterprise Profile

Basic Information

NKMAX's philosophy is "Health is the greatest wealth." The company and its employees are committed to improving the quality of life and saving lives, whether through the development of new immunotherapies, providing new diagnostic tests, or offering research reagents that are vital to the advancement of life sciences for the research community. NKMAX has developed the world's first and only commercialized NK cell activity test. In addition, NKMAX provides high-quality health supplements to help boost the immune system. NKMAX has recently expanded its business into the cell therapy market, focusing on the immune system, and has developed an immunotherapy called SuperNK, which overcomes the limitations of existing NK cell therapies. NKMAX aims to provide the safest and most effective immunotherapy. The company is developing a unique natural killer cell immunotherapy that harnesses the power of the human immune system to fulfill its mission and vision of becoming a leader in the global healthcare industry.
NKMAX Co., Ltd.
Seongnam,GyeonggiProvince,SouthKorea
101~500 people
January 01, 2003
info@nkmax.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Immunological Techniques Cell Technology
Concept
Immune System Diseases Therapeutic Products Lung Cancer
Application Scenarios
Biologics Innovative Drugs